Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). (Q46514298)
Jump to navigation
Jump to search
scientific article published in July 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). |
scientific article published in July 2008 |
Statements
1 reference
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). (English)
1 reference
Sergio Sosa-Estani
1 reference
Salim Yusuf
1 reference
Alvaro Avezum
1 reference
Jose Antonio Marin-Neto
1 reference
Anis Rassi
1 reference
Carlos A Morillo
1 reference
Stuart J Connolly
1 reference
Fernando Rosas
1 reference
BENEFIT Investigators
1 reference
1 July 2008
1 reference
1 reference
156
1 reference
1
1 reference
37-43
1 reference
Identifiers
1 reference
1 reference